NIH’s incubator, the Blueprint MedTech Program https://neuroscienceblueprint.nih.gov, supports innovators developing groundbreaking medical devices by accelerating the development of cutting edge diagnostic and therapeutic neurotechnologies.
The program released two funding notices August 20, 2021, seeking applications from academic and industry applicants who have innovative early stage technologies that aim to improve the diagnosis and/or treatment of nervous system disorders.
Awards up to $1,500,00 per year are available to the most promising and innovative neurotechnologies to help support their development towards commercialization. Awardees will have access to planning resources, access to translational services and expertise, assistance from consultants, and advice from industry experts.
For more information on the NIH Blueprint for Neuroscience Research program, go to https://neuroscienceblueprint.nih.go/neurotherapeutics/blueprint-medtech/blueprint-medtech
For more information on the Blueprint MedTech: Translator (UG3/UH3) funding notice, go to https://grants.nih.gov/grants/guide/pa-files/PAR-21-314.html
To address the small business community, the NIH Blueprint MedTech: Small Business Translator program open to eligible U.S small business concerns, also published a funding notice August 20, 2021. The notice seeks to pursue translational activities and limited size clinical studies to advance the development of diagnostic devices for disorders that affect the nervous or neuromuscular systems.
For more information on the Blueprint MedTech: Small Business Translator (U44) funding notice, go to https://grants.nih.gov/grants/guide/pa-files/PAR-21-282.html.
New applications for both funding notices can be submitted starting October 20, 2021.